NDO is a dysfunction of the bladder that results from congenital conditions... Mar 26
Pfizer inc. and OPKO Health Inc. announced today that the USFDA has accepted for filing the initial Biologics License Application for somatrogon, a long-acting ... Jan 05
Pfizer Inc. today announced that the U.S. FDA has accepted and granted priority review to the Company’s supplemental New Drug Application for XALKORI ... Sep 23
-Advertisements-